Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device
Status:
Terminated
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The study is performed to collect long-term data on the treatment adherence and patient's
acceptability when Zomacton®10 mg is administered with the Zomajet® Vision X device in
patients with a growth hormone deficiency or Turner's syndrome.